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CHAPTER I 
RATIONALE 
The biosynthetic route for the production of free 
cytok in ins remains an unresolved issue. Al though de novo 
biosynthesis has been demonstrated in tobacco and slime 
mold (Chen & Melitz, 1979; Nishinari & Syono, 1980b; Taya 
et al., 1978), the exact contribution of this pathway and 
the tRNA-dependent pathway is as yet unknown. 
The identification of de novo biosynthesis of 
cytokinins in non-plant systems is of considerable interest 
in view of the effects of free cytokinins on mammalian 
tissues. It is the intent of this study to provide direct 
evidence for the de novo pathway in the yeast Saccharomyces 
cerevisiae. This laboratory has previously reported the 
existence of free isopentenyladenosine (I6Ado) in a yeast 
mutant deficient in isopentenylated tRNA (Laten & Zahareas-
Doktor, 1985). The present study focuses on the development 
of an assay for the detection of an enzyme activity responsible 
for the tRNA-independent biosynthesis of cytokinins. This 
goal was facilitated by the use of a mutant s. cerevisiae 
strain, mod 5-1, which lacks the tRNA-d2-isopentenyl transferase, 
thus eliminating a major competitor for substrates. 
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CHAPTER II 
REVIEW OF RELATED LITERATURE 
Cytokinins--Plant Growth Hormones 
Cytokinins are a collection of molecules first 
identified in plants as growth factors which induce cell 
division. Structurally they are defined as N6-substituted 
adenine derivatives. A correlation between structure and 
function of these molecules has been sought by the use of 
bioassays. Typically, the detection of cytokinin activity 
is measured utilizing a bioassay which is based on in vitro 
growth of plant tissue. For example, the tobacco bioassay 
(Linsmaier & Skoog, 1965) is capable of detecting concen-
trations in the nanomolar range. The most potent naturally 
occurring cytokinins appear to be N6-isopentenyladenine 
(I6Ade) derivatives. Figure 1 illustrates some common 
naturally occurring cytokinins. Apparently stringent N6 
side chain requirements must be met since optimal activity 
occurs with an isopentenyl group; activity decreases pre-
cipitously with changes in the n-alkyl chain length by 
about ten-fold for each C-atom added or subtracted (Skoog & 
Schmitz, 197 9) • Extensive studies have been done to delineate 
specific structure-activity relationships (Chen et al., 
1975; Hecht et al., 1975; Henderson et al., 1975). In 
2 
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Figure 1. Structures of some naturally occurring 
cytokinins: a. Isopentenyladenosine; b. trans-Zeatin; 
c. Isopentenyladenine; d. Zeatin Riboside; e. cis-Zeatin 
a. 
b. 
0 0 
H H 
d. 
c. 
H 
5 
spite of these studies, it appears that one specific structural 
property cannot be correlated with cytokinin activity. 
Skoog and Schmitz (1979) have proposed that it is the 
integrated properties of the molecule which act in concert 
to determine the ultimate biological activity. 
The first compound discovered to cause cell division 
was termed kinetin (Miller et al., 1956) and has since been 
replaced by the general term cytokinin (Skoog et al., 
1965). Since their initial discovery, a multitude of 
effects have been attributed to cytokinins. Currently it 
is known that these molecules, interacting with other plant 
hormones (auxins and gibberellins), influence differentiation 
of tissues, organogenesis, leaf growth, apical dominance, 
development of stolons, dormance and germination of seeds, 
and reproductive development (Skoog & Schmitz, 1979). 
Correlations have been drawn to the animal hormone system 
in that cytokinins are thought to be synthesized in specific 
areas and then translocated to target organs. Sites of 
cytokinin biosynthesis in plants are thought to include 
root tips, the developing seed, and the developing bud 
(Leth am , 19 7 8 ) • 
At the molecular level, cytokinins appear to stimulate 
protein synthesis at the transcriptional and translational 
level. Apparently cytoki n ins can either activate pol yr ibosomes 
or stimulate ribosomes to form polyribosomes thereby enhancing 
the translational process (Szweykowska et al., 1981). 
6 
Direct evidence demonstrated increased RNA synthesis in a 
cell-free system. Addition of cytokinins to a mixture of 
DNA from pea buds, RNA polymerase and a receptor protein 
isolated from chromatin increased the rate of RNA synthesis 
(Matthysse & Abrams, 1970). 
Analogous to the animal hormone system, cytokinin 
receptors have been identified in plants. Although several 
investigators have characterized binding parameters for 
these proteins, their physiologic importance has not as yet 
been explained. The first soluble cytokinin binding protein, 
CBF-1, was isolated from wheat germ ribosomes which exhibited 
both high affinity and specificity (Fox & Erion, 1975). 
This study indicated that only one-third to one-fourth of 
the binding protein was associated with the ribosomes. 
Other investigators 
identical to CBF-1 
report binding moieties apparently 
(Moore, 1979; Poly & Davis, 1978). 
These studies report a lesser amount of binding protein in 
association with the ribosomal fraction. Interestingly, 
the cytokinin concentrations supporting growth in vivo are 
approximately ten-fold less than the reported Kd. 
Isopentenyladenosine in tRNA 
In addition to their occurrence as plant growth 
factors, cytokinins have been identified as modified bases 
in tRNA. tRNAs contain a large number of modified bases. 
The modifications are most common in the single-stranded 
7 
loops. A purine base adjacent to the 3' end of the anticodon 
is commonly hypE;?rmodified, and many of these bases have 
cytokinin activity. 
tRNA are known to 
Hypermodifications at this position in 
occur in all organisms yet examined 
including bacteria, plants, and animals (Hall, 1971). A 
further generalization restricts cytokinin moieties to 
those tRNA species which respond to codons beginning with 
uridine (Letham & Palni, 1983). Two studies which examined 
the distribution of cytokinins in different yeast and 
E.coli tRNA species (Armstrong et al., 1969a; 1969b) 
contributed evidence for this generalization. S. lactis 
and s. cerevisiae tRNA was fractionated on DEAE-cellulose 
and then hydrolysed to nucleosides for use in the tobacco 
bioassay. Utilizing this protocol, these investigators 
identified cysteine tRNA as a cytokinin-containing tRNA 
species. Those yeast tRNA species which correspond to 
codons beginning with G (alanine, aspartate, glutamate, 
glycine, and valine tRNA's) were found not to contain 
cytokinins. Previous studies identified a serine tRNA in 
rat 1 i ver (Staehel in et al., 196 8) , tyrosine, tryptophan, 
cysteine, phenylalanine, leucine, and serine tRNA's in 
yeast (Armstrong et al., 1969b) and tyrosine tRNA from 
yeast (Madison et al., 1967) to contain cytokinins that 
correspond to codons with U in the first position. 
The parent nucleoside, isopentenyladenosine (I6Ado), 
and its many derivatives appear to exhibit some species 
8 
specificity (Lethan & Palni, 1983). I6Ado is the only 
cytokinin which occurs in yeast and animal tRNA, as well as 
in most organisms. Bacteria possess mainly methylthio 
derivatives. Hydroxylated derivatives such as cis- and 
trans-ribosylzeatin seem to predominate in plants. One 
exception to this is evident in the plant pathogenic bacteria, 
Agrobacterium tumefaciens. This pathogen induces tumor or 
gall formations in plants which secrete cytokinins. It has 
been found that this bacterium contains the hydroxylated 
derivative, ribosylzeatin in its tRNA (Cherayil & Lipsett, 
1977) and primarily occurs in tRNA-ser and tRNA-leu (Morris 
et al., 1981) • Morris et al. suggest that this pl ant-associated 
prokaryote has acquired genetic material from the host. 
It is yet unclear whether the presence of cytokinins 
in tRNA is related to the growth-promoting function. A 
relationship has been established between tRNA-associated 
cytokinins and protein synthesis. More specifically, 
studies indicate that a modified base adjacent to the 3' 
end of the anticodon facilitates binding of the charged 
tRNA to the mRNA-ribosome complex. Fittler and Hall (1966) 
were able to selectively modify the 16Ado component of 
yeast seryl-t-RNA with iodine treatment. Their results 
showed that this chemical modification did not alter amino 
acid acceptor function, but did interfere with the association 
between tRNA and the mRNA-ribosome complex in vitro. This 
finding was supported by Gefter and Russell (1969) using 
9 
E. coli. Using a transducing bacteriophage, phi 80, the 
synthesis of three forms of suppressor tyrosine tRNA occurred, 
differing only in the extent of modification of the base 
adjacent to the anticodon. The fully modified form was 
able to support in vitro protein synthesis and exhibited 
normal ribosome binding. The form lacking the modification 
was inefficient in in vitro protein synthesis and ribosome 
binding ability was diminished. It has been suggested that 
hypermodification of the base adjacent to the anticodon 
prevents misreading of the codon and insures the single-
stranded conformation of the anticodon loop (Parthasarathy 
et al., 1974). Also in E.coli it appears that the thio-
methylated r6Ado containing tRNA binds better to ribosomes 
than I 6Ado (Hoburg et al., 197 9) • It has been shown that 
the loss of hypermodification at this position does not 
effect protein synthesis at the level of aminoacylation 
(Laten et al., 1980). 
The isoprene side chain of r6Ado containing tRNA 
is derived from the sterol b iosynthet ic pa th way (Fig. 2) • 
Several investigators were involved in elucidating the 
isopentenylation of tRNA (Fittler et al., 1968a, 1968b; 
Holtz & Klambt, 1975; Kline et al., 1969; Murai et al., 
1975; Peterkofsky, 1968; Rosenbaum & Gefter, 1972). Fittler 
et al. (1968a) established the precursor relationship 
of mevalonate to the d2-isopentenyl group in tRNA of Lacto-
bacillus. Using mevalonate-requiring strains grown in the 
10 
Figure 2. The sterol biosynthetic pathway. d2-ipp 
is an intermediate in this pathway and serves as the donor 
substrate in the isopentenylation of tRNA. 
11 
STEROL BIOSYNTHETIC PATHWAY 
Acetyl CoA + Acetoacetyl CoA 
J 
HMG-CoA 
J 
mevalonate 
t 
' 
' 3-ipp ... -.-.. 2 ipp ~ J 
squalene 
J 
sterols 
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presence of i4c-mevalonate, all the tRNA-associated radio-
activity could be accounted for by the isopentenyl group of 
r6Ado. Crude enzyme extracts from yeast and rat liver were 
isolated which catalyzed the incorporation of mevalonate or 
d2-isopentenylpyrophosphate (d2-iPP) into preformed tRNA in 
vitro (Fi ttler et al., 1968b). This study demonstrated 
that isopentenylation occurs at the macromolecular level 
and not at the mononucleotide level. Other studies indicated 
that a specific adenosine residue of tRNA serves as the 
acceptor of the d2-isopentenyl group in yeast. Treatment 
of tRNA with permanganate cleaves the d2-isopentenyl group 
from tRNA, yielding a suitable substrate for tRNA-d2-iso-
pentenyltransferase. Iodine treatment prevents permanganate 
from reacting with the isopentenyl group, and the tRNA will 
not accept an isopentenyl group in the transferase reaction. 
The donor molecule in the reaction was found to be exclusively 
d2-iPP and not d3-ipp (Kline et al., 1969). This isomerization 
is catalyzed by isopentenylpyrophosphate isomerase (EC 
5.3.3.2) which was initially isolated from yeast (Agranoff 
e t a 1 • , 1 9 6 8 ) • O t he r i n v es t i g a tors have des c r i bed th i s 
enzyme in porcine liver (Holloway & Popjak, 1967, 1968; 
Shah et al., 1965) and avian liver (Sagami & Ogura, 1983). 
The discovery and isolation of naturally occurring 
I6Ado-deficient tRNA facilitated the study of the tRNA-d2-
isopentenyltransferase reaction as well as the pathway 
leading to free r6Ado levels (Gefter & Russell, 1969; Laten 
13 
et al., 1980). In addition to tRNA as substrate, Holtz and 
Klambt (1978) have demonstrated isopentenylation of oligonuc-
leotides by tRNA-a2-isopentenyltransferase from Zea mays 
L., albeit at a reduced preference for the enzyme. 
Biosynthesis of Free Cytokinins 
Apart from their occurrence as components of tRNA, 
free cytokinins are found in plants (Letham & Palni, 1983), 
some plant pathogenic bacteria (Palni et al., 1983) slime 
mold (I hara et al., 1984) , yeast (La ten & Zahareas-Dokto r, 
1985), and plant-associated insects (Elzen, 1983). In 
recent years much attention has been focused on the elucidation 
of the biosynthetic pathway responsible for the production 
of free cytokinins. Two pathways have been postulated. 
Since cytokinins are components of tRNA, one theory postulates 
that the natural turnover of tRNA provides the free cytokinin 
pool. The alternate hypothesis is that a de novo pathway 
independent from tRNA turnover, is responsible for the 
synthesis of the free forms. A plethora of direct as well 
as indirect evidence has accumulated in favor of both 
pathways. It appears likely that both mechanisms may be 
integral in contributing to the free cytokinin pool, however 
each organism may differ in the mechanism acting as the 
major pathway. For example, experiments conducted by 
Helbach and Klambt (1981) suggested that tRNA and oligonuc-
leotide turnover is the only active pathway in the b~cteria 
14 
Lactobacillus acidophilus. By supplying this mevalonate 
auxotroph with 14c-mevalonate in a pulse-chase experiment, 
these researchers were able to specifically label the 
cytokinin-containing nucleic acids. The appearance of 
labelled free cytokinins was monitered as well as the 
incorporation into tRNA. Following the time course of 
pulse labelled tRNA, it was apparent that as the tRNA 
turned over, the label was found to increase in the free 
cytokin ins. These results are in agreement with previous 
studies which determined the half-life of L. acidophilus 
tRNA to be three hours (Helbach et al., 1978). 
Much interest has been focused on determining the 
pathway of free cytokinin production in higher plants since 
there is an associated hormone action. An early study 
which attempted to clarify whether a de novo pathway existed, 
utilized a cytokinin-autonomous line of tobacco tissue 
(Dyson & Hall, 1972). Cytokinin-dependent tobacco tissue 
and the autonomous line were similar in that both contained 
r6Ado and ribosylzeatin within the tRNA, but differed in 
that the autonomous line contained an appreciable level of 
I6Ado in the free state. If tRNA turnover provides the 
cell with free cytokinins, why is the cytokinin-dependent 
tissue devoid of any free r6Ado? 
Again employing the autonomous tobacco tissue, Chen 
et al. (1976) were able to provide evidence for the tRNA-inde-
pendent biosynthesis of cytokinins. 14c-Adenine and a 
15 
14c/3H-labelled adenosine analog were supplied. It was 
found that the tissue was capable of synthesizing labelled 
I6Ado and its derivatives. It was unlikely that the 14c/3H-
I6Ado resulted from tRNA turnover since the 14c/3H adenosine 
analog was shown not to be incorporated into tRNA. Charac-
terization of labelled free cytokinins in a cytokinin-autonomous 
tobacco eel 1 1 ine when 3H-aden i ne was supplied was accomplished 
by Sephadex LH20 chromatography and reverse phase HPLC 
(Burrows, 1978). The major radioactive cytokinins produced 
included I6Ade, I6Ado, trans-ribosylzeatin, and trans-zeatin. 
Since the cis isomer of zeatin and the oxidized form t-io6Ado 
are found in tRNA, it was improbable that the free cytokinins 
were tRNA degradation products. A similar follow-up qualitative 
study compared cytokinins of tRNA and free forms from 
Lupinus luteus L. seeds and Populus x robusta schneid 
leaves. Once again the free forms differed from the tRNA-
associated species. Although these results do not preclude 
a tRNA turnover pathway, they strongly support the importance 
of a de novo pathway. 
The first piece of direct evidence for the de novo 
pathway came from the slime mold, Dictyostelium discoideum 
(Taya et al., 1978). These cells contained a large quantity 
of I6Ade which is thought to be a precursor to the spore 
germination inhibitor, discadenine. This study, utilizing 
a cell-free system, demonstrated that 5'-AMP was the direct 
precursor of free cytokinins. The reaction mixture consisted 
16 
0 f 14 C - i PP , c rude en z ym e ex tr a c t , b o i 1 e d non - d i a 1 y s e d 
supernatant (cell extract) in buffer at pH 7. 5. After a 
one hour incubation, the mixture was extracted with ethyl 
acetate, chroma tographed on silica gel, and scanned with a 
radiochromatogram scanner. A radioactive product was 
identified as r6Ade. This experimental design implicated 
that a heat-stabile dialyzable substance was the acceptor 
of the isopentenyl group. Various compounds such as 5'-AMP, 
ADP, ATP, and 3',5'-cAMP were tested, and 5'-AMP was found 
to be the direct acceptor. 
Additional direct evidence in cytokinin-autotrophic 
tobacco tissue cultures was reported by Chen and Melitz 
(1979). In this study, the investigators isolated an 
enzyme system capable of catalyzing the synthesis of I 6Ado-5 '-P 
from d2-iPP and 5'-AMP. r6Ado and r6Ade were also detected 
among the react ion products, but only when a crude enzyme 
preparation was used. The authors suggested these molecules 
were degradation products modified by nucleosidases and 
phosphatases. Chen (1982) reported dual-labelled products 
when (2,8-3H)Ade and (l-14c) d3-iPP were supplied in the 
culture medium. Analysis of these products by GLC revealed 
r6Ado, r6Ade, zeatin, and ribosylzeatin. Formation of the 
hydroxylated derivatives was attributed to microsomal mixed 
function oxidases. 
d2-iPP:5'-AMP-d2-isopentenyltransferase was further 
purified approximately 48-fold when compared to the crude 
17 
extract, with a specific activity of 78 nmol I6Ado-5 '-P/min/mg 
protein. The molecular weight of partially purified enzyme 
was estimated by Sephadex G-200 gel filtration to be 52,000 
+/-2000. In characterizing the enzyme, optimal activity 
was achieved at pH 7.0, with an absolute requirement for 
Mg2+ ion. The enzyme is specific for d2-iPP and 5 '-AMP. 
Ado, Ade, cAMP, GMP, Gua, and Ino could not be substituted 
as the acceptor molecule. Chen concluded that although 
14c-d2-iPP and 3H-adenine condensed to yield 14c/3H dual-
label led cytokinin products in vivo, adenine was not a 
substrate for the isopentenyltransferase in vitro. He 
speculated that other enzymes may be involved in the de 
~ biosynthesis of cytokinins. The alternate explanation 
was that the dual-labelled in vivo products may be the 
result of incorporation into tRNA that subsequently turned 
over. 
Ihara et al. (1984) later purified d2-isopentenyl-
pyrophosphate:5'-AMP d2-isopentenyltransferase 6800-fold 
from D. discoideum. 5 '-AMP was shown to be the preferred 
substrate, however it was observed that ADP was 60-80% as 
effective as 5 '-AMP. In comparing this enzyme to that 
isolated from tobacco (Chen, 1982) both similarities and 
differences were observed. Both enzymes have a requirement 
for Mg2+ ion, and a pH optimum of 7.0. However the slime 
mold enzyme demonstrated higher enzyme activity with zn2+ 
and Mn2+. The slime mold enzyme molecular weight was 
18 
estimated by Sephadex G-100 gel filtration to be 40,000 +/-
2000 Da, which is close to the 52,000 +/- 2000 Da estimate 
made for the tobacco enzyme. The Km of the tobacco eel 1 
enzyme for 5 '-AMP is 4 7 times higher than the reported Km 
for slime mold. 
As eluded to previously, plant pathogenic bacteria 
induce the formation of tumors or crown-gall disease, 
although the bacteria are not present in these tissues. 
These galls produce large amounts of cytokinins. Stuchbury 
et al. (1979) observed that radiolabelled adenine was 
rapidly converted to ribosylzeatin phosphates, zeatin and 
ribosylzeatin in vivo. Considering the tRNA in higher 
plants was estimated to have a half-life of 3-5 days, 
(Klemen & Klambt, 1974) a pathway involving tRNA incorporation 
prior to release seemed unlikely. 
In an attempt to discern the maximum contribution 
of tRNA turnover to free cytokinin levels, Barnes et al. (1980) 
grew potato cells in liquid culture in the presence of 
mevalonic acid lactone-(2-14c) and calculated the relative 
rate of cytokinin release by tRNA turnover. It was concluded 
that tRNA turnover could account for no more than 48% of 
the free cytoki n in pool. 14c-aden ine pulse-chase ex per imen ts 
using roots from the bean, Phaseolus vulgaris, indicated 
that primary incorporation occurred in tRNA and secondarily 
in oligonucleotides and mRNA (Maass & Klambt, 1981). 
Nishinari and Syono (1980b) reported findings 
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similar to Taya et al. (1978) and Chen and Melitz (1979) 
demonstrating cell-free biosynthesis of cytokinins in 
cul tur ea tobacco cells. However, in addition to 5'-AMP, 
they found that adenine and adenosine also served as substrates 
for the enzyme. Subsequently, a pa th way was pro po sea 
involving 14c-aaenosine incorporation into butanol soluble 
cytokinins in vivo in synchronously dividing cells (Nishinari 
& Syono, 1980c) and was compared to the previous in vitro 
study. The results indicated discrepancies between the in 
vitro and in vivo pathways. These authors currently are 
working to clarify these differences. It seems likely that 
in vivo, rapid interconversion of metabolites occurs due to 
the presence of other enzymes. This would explain the 
inability to detect rapidly converting intermediates. 
Palni et al. (1983) were able to determine the 
significance of nucleotides in V. rosea crown-gall tissue 
in the biosynthesis of free cytokinins. Using anion exchange 
chromatography, distinct separation of the mono-, di-, and 
triphosphates was achieved. These studies led to the 
conclusions that trans-zeatin monophosphate was the main 
active nucleotide, that biosynthesis probably occurred at 
the mononucleotide level, and that it was tRNA-independent. 
Recently, the gene responsible for cytokinin bio-
synthesis was cloned from Agrobacterium tumefaciens, the 
crown-gall inducing bacterium (Barry et al., 1984). The 
virulence plasmid Ti of A. tumefaciens contains a small 
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region called the tmr locus which is associated with phyto-
hormone metabolism. This region was cloned into E. coli 
cells using a plasmid. Expression .was maximized using a 
strong E. coli promoter and confirmed by an isopentenyltrans-
ferase assay. The reaction was found to be specific for 
5'-AMP and iPP. Adenosine could not be used as substrate. 
E. coli was suitable for this study since it has been shown 
to lack the d2-isopentenyltransferase enzyme. 
From the above discussion it is apparent that there 
is some ambiguity in the acceptor substrate for the isopentenyl 
group. Chen and coworkers (1979, 1982) report 5'-AMP to be 
the direct acceptor in tobacco tissue culture. Taya et 
al. (1978) and Ihara et al. (1984) both studying D. discoideum 
also report 5'-AMP as well as ADP to be involved. Nishinari 
and Syono (1980b), observed that 5 '-AMP, adenine, and 
adenosine all are equally suitable substrates although this 
group reports differences between in vitro and in vivo 
studies. Palni et al.(1983) and Barry et al. (1984) also 
agree that the acceptor molecule is a mononucleotide. Van 
Staden and Forsyth (1984), attempted to clarify the role of 
adenine and adenosine in the pathway leading to free cytokinins 
in excised maize roots. It has been suggested that roots 
are sites of cytokinin biosynthesis (van Staden & Smith, 
1978). This study showed that no incorporation of label 
could be found in the biologically active cytokinins when 
14c-adenine and 14-adenosine was supplied to the media. 
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They suggested several possibilities 
1. Adenine and adenosine may not serve as precursors. 
2. Roots are unable to isopentenylate adenine or 
adenosine. 
3. The isopentehyl side chain was not available in 
the experimental system. 
So it sppears that the identity of the direct acceptor 
molecule is still unclear. In reviewing the purinebiosynthetic 
pathway (Fig. 3), it appears that only few molecules are 
likely candidates as the acceptor of the isopentenyl group. 
Cytokinin Effects in Mammalian Cells 
To date, the only established function of free 
endogenous cytokinins is that of potent growth stimulation 
in higher plants. The only non-plant systems so far shown 
to contain free cytokinin molecules are yeast (Laten & 
Zahareas-Doktor, 1985) and slime mold (Taya et al., 1978). 
The only identified function of these molecules is in slime 
mold, where I6Ade has been identified as a precursor to the 
spore germination inhibitor, discadenine. The evidence 
that has accumulated strongly suggests that these molecules 
are not the products of tRNA turnover. Since these modified 
nucleosides are known components of mammalian tRNA, it is 
of interest whether any function can be associated with 
them after release following normal turnover. 
It has been reported that I6Ado stimulates mitosis 
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Figure 3. The purine biosynthetic pathway. Adenine, 
adenosine and AMP are the only structures which contain an 
amino nitrogen at position 9 on the purine heterocyclic 
ring. Precursors to these molecules are incapable of 
isopentenylation due to the presence of a keto group. 
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in human lymphocytes at low concentrations (10-7 M) and 
inhibits at higher concentrations (10-6 M) (Gallo et al., 
1969). These cells were pretreated with phytohemagglutinin 
which causes a morphological transformation yielding a cell 
capable of DNA synthesis, followed by mitosis in vitro. 
Without this treatment, in vitro studies of DNA synthesis 
and mitosis would not be possible. These authors propose 
that DNA synthesis inhibition may be due to I6Ado competing 
with adenosine or ATP. 
I6Ado also exhibits anti-tumor activity. Several 
tumor types have been shown to be susceptible to I6Ado 
treatment including trophoblastic tumor cells (Trewyn & 
Kerr, 197 9) and lymphocyt i c leukemic eel 1 s (Gr ace et al., 
1967). It has been postulated that I6Ado competes with 
coenzymes containing adenosine for the enzyme binding site, 
and thus can inhibit a large number of metabolic enzymes 
(Tritsch, 1973). 
I6Ado has also been shown to elicit immunosuppressive 
effects (Hacker & Feldbush, 1969). More specifically, 
I6Ado inhibited the incorporation of uridine into RNA and 
thymidine into DNA in phytohemagglutinin transformed rat 
spleen cells. Interestingly, when I6Ado is conjugated 
to albumin and injected into rabbi ts, an unusually strong 
antibody response is elicited (Humanyun & Jacob, 1974). 
This response is in contrast to the relatively weak titres 
observed after immunization with the common nucleotide-albumin 
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conjugates. This result suggests that I6Ado is not a 
normally circulating compound and is thus recognized as 
foreign. This finding is curious in view of the reported 
immunosuppressive effects of the free nucleoside. 
A more recent study (Quesney-Huneeus et al., 1980) 
identifies I6Ado and zeatin as mediators of DNA replication. 
It has previously been determined that mevalonate production 
is linked to maintaining normal cell growth, and that 
uncontrolled mevalonate synthesis is characteristic of all 
malignant and premalignant tumors in vivo. Quesney-Huneeus 
et al. (1980) demonstrated that I6Ade and zeatin were 100 
times more active in restoring DNA synthesis to cells which 
were blocked by compact in (HMG CoA reductase inhibitor), 
than mevalonate itself. More specifically, it was found 
that I6Ade and zeatin were specific for S-phase DNA synthesis. 
Equally interesting is the finding that both I6Ade and 
mevalonate can reverse inhibition of DNA synthesis induced 
by nalidixic acid. This finding suggests I6Ade may be 
exerting regulatory effects on DNA gyrase, which is the 
enzyme that catalyzes the negative supercoiling of circular 
DNA in bacteria. In prokaryotes, DNA gyrase has been shown 
to be specifically inhibited by nalidixic acid. This study 
has important implications as to how I6Ade may be involved 
in maintaining replicative homeostasis in the normal cell 
and in the pathophysiology of malignancy. These latter 
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results further confuse the mechanism of anti-tumor effects 
exerted by exogenously supplied r6Ade. 
CHAPTER I I I 
MATERIALS AND METHODS 
Growth of Cells 
Two strains of Saccharomyces cerevisiae were employed, 
wild type (HL370) and mod 5-1 (HL430). The wild type cells 
were grown in liquid YPD medium (1.0% yeast extract, 2.0% 
dextrose, 2.0% peptone), SD+ YE medium (0.67% yeast nitrogen 
base w/o amino acids, 2.0% dextrose, 0.1% yeast extract) or 
YPG medium (1.0% yeast extract, 2.0% peptone, 3.0% v/v 
glycerol). The mod 5-1 
(YPD + 0.003% adenine). 
strain was grown in YPAD medium 
14c-adenine labeling experiments 
made use of wild type cells grown in SD + YE media, while 
YPG media was used for experiments testing mitochondrial 
expression. All other experiments utilized mod 5-1 cells 
grown in YPAD media. The cells were grown at 30 Cina 
shaking water bath to an optical density corresponding to 
mid-log phase on the growth curve. The cells were harvested 
by c en tr i f u g a t i o n a t 5 0 0 0 rpm i n an SS -3 4 r o to r f o r 2 0 
minutes. 
Cell Breakage 
Buffer A (10 mM Tris-HCl, pH 7.5; 10 mM magnesium 
acetate; 6.0 mM KCl; 1.0 mM EDTA; 6.0 mM 2-mercaptoethanol; 
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25% glycerol, w/v; 25% polyvinyl polypyrrolidone, w/v) or 
buffer B (10 mM .Tris-HCl, pH 8.0; 10 mM magnesium acetate; 
60 mM KCl; 1.0 mM EDTA; 6.0 mM 2-mercaptoethanol; 10% 
glycerol, w/v) was added to the yeast paste in the ratio of 
2.0 grams of buffer per gram wet weight of cells. The 
cells were then broken by using glass beads in a blender. 
The homogenization was carried out at 0-4 degrees C for 15 
second intervals for a total time of 3.0 minutes. 
The cellular debris was removed by centrifugation 
at 30,000 x g. The supernatant was retained and protein 
was assessed by the method of Lowry et al. ( 1951). 
Isopentenyl Pyrophosphate Isomerase 
Preparation 
A crude iPP isomerase enzyme preparation was obtained 
from wild type bakers yeast (Agranoff et al. 1960). The 
cells were broken using 2.0 M Tris buffer, pH 7.0. The 
cellular debris was removed as previously described. The 
resultant supernatant was exhaustively dialyzed against 
buffer C (0.02 M Tris-HCl, pH 7.5; 0.3 M KCl; 0.01 M MgCl2; 
0.1 M EDTA), and protein was determined by the method of 
Lowry et al. (1951). 
A more purified enzyme preparation was prepared by 
Mrs. Ruth Timmons from pig liver & Popjak, 1967). 
Isopentenyl Pyrophosphate Isomerase 
Enzyme Assay 
Assay for the yeast enzyme was performed by the 
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method of Agranoff et al. (1960). The reaction mixture 
contained 3.0 urnoles Mg Cl2; 2.0 urnoles Tris, pH 8.0; 0.1 
urnole 14c-d3-iPP (57 rnCi/rnrnol) and 1.0 mg. of protein, in a 
f in a 1 v o 1 urn e o f 0 • 5 rn 1 • Aliquots were removed and the 
reactions were terminated by the addition of 6.0% TCA at 0, 
10, 20, 40, 60, and 120 minutes. 
The tubes were centrifuged in a clinical centrifuge 
and the supernatant was extracted with ether. An aliquot 
of the aqueous layer was placed on glass fiber discs, the 
discs were put into scintillation vials along with 5.0 ml 
of toluene based scintillation cocktail and counted in a 
Packard Tri-carb liquid scintillation counter. As d3-iPP 
is converted to d2-iPP the radioactivity decreases in the 
aqueous layer; therefore isornerase activity is detected by 
a decrease in counts as the reaction proceeds. Activity is 
expressed in nrnol/rnin/rng protein. 
AMP-d2-rsopentenyltransferase 
Preparation 
Approximately 3.0 grams of mod 5-1 cells were 
harvested and mechanically lysed in either buffer A or 
buffer B. After removal of the cellular debris by centrifu-
gation, the supernatant was precipitated with ammonium 
sulfate. The fractions precipitating between 20-90% were 
collected by centrifugation at 20,000 x g for 20 minutes, 
resuspended in a small volume of buffer and dialyzed against 
three changes of the same buffer. A protein assay was 
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performed on the dialysate (Lowry et al., 1951), and the 
protein solution was concentrated to either 100 mg/ml or 10 
mg/ml using Millipore CX-10 immersible ultrafilters. The 
enzyme preparation was kept at 0-4 degrees C throughout the 
procedure, and was used immediately in the enzyme assay 
(Fig. 4). 
AMP-d2-Isopentenyltransferase Assay 
14c-labelled d3-iPP (57 mCi/mmole, Amersham) was 
incubated in either buffer D (7.0 mM Tris-HCl, pH 7.0; 
20 mM MgCl2; 35 mM MnCl2; 3.5 mM 2-mercaptoethanol; 7.0 mM 
KF) or buffer E (20 mM Tris-HCl, pH 7.5; 5.0 mM magnesium 
acetate). At time zero, an iPP isomerase preparation from 
porcene 1 iver or Baker's yeast was added to the reaction. 
At 15 minutes, the isopentenyl acceptor substrate was added 
(5'-AMP, adenine, or adenosine) as well as the isopentenyl-
transferase preparation (0.25-1.3 mgs). Isotopically 
labelled acceptor molecules included 3H-5 '-AMP (11. 7 Ci/mmole, 
Amer sham) or 3H-Adenosine (41 Ci/mmole, Amersham). The 
reaction was terminated at various times (5, 10, 15, 30, 
60, and 90 minutes) by the addition of one volume of ethanol 
or by cooling on ice. Controls were assayed in parallel 
using boiled isopentenyltransferase and/or iPP isomerase 
preparations. 
see Table 1. 
For specific experimental assay parameters, 
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Figure 4. Preparation of crude yeast isopentenyl-
transferase. The summarized procedure describes the method 
of crude enzyme preparation. 
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Identification of Biosynthetic Products 
Several schemes were employed in the identification 
of the biosynthetic products. These included: 
(A) Anion exchange chromatography, followed by 
Sephadex LH-20 chromatography, and reverse phase high 
performance liquid chromatography (HPLC). 
(B) Sephadex G-25 chromatography followed by reverse 
phase HPLC. 
(C) Direct analysis on reverse phase HPLC. 
Dowex anion exchange resin was swollen in aqueous 
.0025 N NaOH. The reaction mixture was applied to the top 
of the column (16 mm x 20 cm) at a flow rate of 15 ml/hr. 
The column was then eluted with a stepwise KCl gradient 
(0.0 M KCl, 0.1 M KCl, 0.3 M KCl; in .0025 N NaOH) and 
fractions were collected (3.0 ml/fraction). 1.0 ml aliquots 
of each fraction were placed in scintillation vials with 10 
m 1 o f A q u a s o 1 ( VWR ) a n d c o u n t e d i n a P a ck a rd T r i - c a r b 
liquid scintillation counter. Radioactive fractions were 
combined and further chromatographed on Sephadex LH-20. 
A small aliquot of the combined radioactive fractions 
(>500 CPM) was applied to a Sephadex LH-20 column (1.5 cm x 
28.0 cm). The radioactive sample was simultaneously chromato-
graphed with authentic cytokinin standards in 33% aqueous 
ethanol at a flow rate of 12.0 ml/hr. The column was 
monitered using a UV spectrophotometer at 254 nm and 1.0 ml 
fractions were collected. Aliquots from each fraction were 
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removed for liquid scintillation counting. 
In some instances, a Sephadex G-25 column was used 
in place of anion exchange chromatography. The eluent used 
was distilled deionized water and the column dimensions were 
10 mm x 10 cm. The reaction mixture was loaded directly 
onto the column and eluted at a flow rate of 14.4 ml/hour. 
Fractions were collected and counted. 
Reverse phase HPLC was utilized for final identifi-
cation. Prior to HPLC injection, samples from Sephadex 
LH-20 and Sephadex G-25 were concentrated either by rotoevap-
oration or under a stream of nitrogen gas. Injection 
volumes varied between 25 ul and 100 ul. The mobile phase 
was aqueous methanol using either isocratic elution (55%) 
or a linear gradient, (30-70%) aqueous methanol. The 
eluent was monitored at 254 nm and the flow rate ranged 
between 0.5 and 1.0 ml/minute. Fractions were collected 
directly into scintillation vials. 
typical elution profile. 
See Figure 5 for a 
14c-Adenine Labelling 
Wild-type yeast cells were grown in SD + YE media 
in the presence of 10 uCi 14c-adenine (53 Ci/mmole). A 10 
m 1 1 i q u id cu 1 tu re was i no cu 1 at ed at 0 • 16 O • D • The c e 11 s 
were harvested after 2.0 hours and 6.0 hours. 3.0 ml 
aliquots were removed at each time point, centrifuged in a 
SE-12 rotor at 8000 RPM for 20 minutes, and washed twice 
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Figure 5. RP-HPLC Elution Profile. The column was 
eluted with a 30-70% aqueous methanol gradient at a flow 
rate of 1.0 ml/min. The following standards were chromato-
graphed: 5'-AMP; 16AMP; Adenosine; t-Zeatin; Zeatin Riboside; 
c-Zeatin; r6Ado; r6Ade. The eluent was monitored by UV at 
254 nm. 
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with cold water. A final concentration of 1.0 ug zymolyase/mg 
yeast eel 1 s was obtained using a solution of 0. 1 mg zymolyase/ml 
Scott's buffer (50 mM KH2P04, 10 mM 2-mercaptoethanol; pH 
7.5). The cell suspension was transferred to microcentrifuge 
tubes and incubated for 3.0 hours at 30 C in a shaking 
water bath. NP-40 was added to a final concentration of 
10% and the suspension was incubated an additional 15 
minutes. The eel 1 s were examined under the microscope to 
confirm cell lysis prior to microcentrifugation for 15 
minutes. The supernatant was retained and 1 oad ed on to a 
Waters Cl 8 Sep-Pak cartridge. The column was washed once 
with 4.0 ml of water, and then with 4.0 ml of methanol. 
The methanol wash was collected in a 50 ml round bottom 
fl ask, rotoevapora ted to dryness, res us pended in a sma 11 
volume of methanol, and injected into the HPLC. The amount 
of radioactivity was checked before and after rotoevaporation. 
CHAPTER IV 
RESULTS 
Isopentenyl Pyrophosphate Isomerase 
Activity 
The activity of the yeast iPP isomerase was calculated 
to be 0.00139 nmol/min/mg protein. The ability of this 
enzyme preparation to convert d3-iPP to d2-iPP was demonstrated 
by two control experiments. The first control consisted of 
boiled transferase enzyme and active isomerase in the 
isopentenyltransferase assay using 5'-AMP and 14c-d3-iPP. 
In the second control, both enzyme preparations were boiled 
in a parallel reaction. Results from the Dowex elution 
profile revealed two peaks of 14c counts corresponding to 
the d2 and d3 forms of iPP from the first control (Fig. 6A). 
The second control yielded only one radioactive peak, 
indicating that the d3 form was present and that isomerization 
had not occurred (Fig. 6b). These results were confirmed 
by comparing the elution of authentic 14c-d3-iPP to the 
controls. 
Isopentenyltransferase Assay 
Several assay parameters were tested in the assay 
of d2-isopentenyltransferase. Since the enzyme had not 
previously been assayed in yeast, initial parameters were 
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Figure 6. Dowex Elution Profiles (Control). The 
reaction mixture was loaded directly onto the column. 
A. The reaction mixture contained boiled isopentenyl-
transferase and active isomerase enzymes. Products eluted 
correspond to a2-iPP and d3-iPP respectively. 
B. The reaction mixture contained both boiled 
isopentenyltransferase and isomerase enzymes. Only one 
peak corresponding to d3-iPP was eluted. 
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modeled after procedures used in slime mold (Taya et al., 
1978) and tobacco (Chen & Melitz, 1979; Nishinari & Syono, 
1980b). Table 1 summarizes the various assay conditions of 
each experiment. Three substrates were tested (5'-AMP, 
adenosine and adenine) for the ability to accept the isopentenyl 
group from d2-iPP. Figure 7 illustrates the reactions 
which were tested. 
5'-AMP as Substrate 
Initially, unlabelled 5'-AMP and 14c-iPP was used in 
the reaction following the procedure of Chen and Melitz 
(1979). Enzymatic products could not be identified when 
this protocol was foll owed. The next set of ex per imen ts 
were conducted using 3H-labelled 5'-AMP and 14c-iPP. In 
these cases, a dual-labelled product which could be identified 
by more than one chromatographic method was anticipated. 
Experiment 4 compared the assay protocol adapted from the 
procedures of Chen and Melitz (1979) to that of Taya et 
al. (1978). Assay conditions modeled according to Chen's 
procedure resulted in a radioactive profile lacking any 
dual-labelled peaks. However the procedure similar to Taya 
et al. yielded two 3H/14c peaks eluting in the first step 
of the gradient (Fig. 8). In the control run, the second 
dual-labelled peak disappeared from the Dowex elution 
profile (Fig. 9). Fractions corresponding to the remaining 
dual-labelled peak (A2) were combined and one ml (3984 cpm 
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Figure 7. Substrates tested in the isopentenyltrans-
ferase assay: 
1. 5 'AMP + d2-iPP 
2. Adenosine + d2-iPP 
3. Adenine + d2-iPP 
1. 
2. 
3. 
NH 
~-, ~-·~N N 
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Figure 8. Dowex Elution Profile: 3tt-5'-AMP + 
14c-iPP (Experiment 4). Two dual-labelled products, Al and 
A2, eluted in the fir st step of the gradient. 3tt cpm are 
represented by the dashed tracing and 14c cpm are represented 
by the solid tracing. 3.5 ml fractions were collected and 
1.0 ml aliquots were taken for liquid scintillation counting. 
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Figure 9. Dowex Elution Profile (Control) 3tt-5'-AMP 
+ 14c-iPP (Experiment 4). Boiled isopentenyltransferase and 
isomerase preparations were used in the reaction. 3tt cpm 
are represented by the dashed line and 14c cpm are represented 
by the sol id 1 ine. Cl and C2 correspond to d2-iPP and 
d3iPP respectively. Peak A2 has disappeared from the 
elution profile. 
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14c, 2292 cpm 3H) was loaded onto a Sephadex LH20 column. 
Standards of authentic r6Ado, r6Ade, and zeatin were co-chrom-
atographed with the sample. Figure 10 illustrates the LH20 
elution profile showing a dual-labelled component which 
elutes just before zeatin. Again the radioactive fractions 
were combined and concentrated by rotoevaporation for HPLC 
injection. Due to the volatility of the compound (radioactive 
counts repeatedly recovered in the trap after rotoevaporation) 
further analysis on HPLC was not possible. In an attempt 
to circumvent the need for rotoevaporation, a quicker 
procedure was adopted for product identification. A Sephadex 
G-25 column was used as described in Materials and Methods. 
This column allowed the separation of most proteins from 
any cytokinin molecules. This step replaced the Dowex 
anion exchange column thus eliminating the alkaline pH 
conditions. Since the G-25 eluent did not contain salt, 
the need for the LH20 column was also eliminated, and 
direct injection into the HPLC was possible. HPLC elution 
profiles of control and experimental assays using this 
protocol clearly indicates a dual-labelled component present 
only in the experimental run. This product eluted just 
prior to the r6Ado standard. The majority of the radioactivity 
in both the experimental (Fig. lla) and control (Fig. llb) 
profiles is associated with fractions containing 5'-AMP and 
I 6AMP standards. Adenine I adenosine I d2 and d3-iPP standards 
are known to chromatograph in this area as well. The same 
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Figure 10. LH 20 Elution Profile. Peak A2 (3984 cpm 14c; 
2292 cpm 3H) obtained from the rection 3H-5'-AMP + 14c-iPP 
was further chromatographed on Sephadex LH 20. Standards 
of r6Ado, r6Ade, and zeatin were co-chromatographed. 
The eluent was monitored at 254 nm. 4.5 ml fractions were 
collected, O. 5 ml aliquots were taken for radioactive 
counting. A single dual-labelled peak was eluted. 
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HPlC Elution --· 3 H·S'-AMP + 14C-iPP-
,...-r-
10 
fraction 
15 
0 
0 
c( 
.., 
20 
3 Figure lla. HPLC Elution Profile: Experimental H-5'-AMP + 14c-iPP (Experiment 7). Standards were ~imul­
taneously in~ected with 50 ul of sample (14,261 cpm H1 
22,092 cpm 1-c) and eluted by a 30-70% a~ueou~ methanol 
gradient. This profile represents products obtained after 
a 30 minute incubation. 1.0 ml fractions were collected, 
0.5 ml aliquots were taken for radioactive counting. 
Dashed bars indicate 3H counts and solid bars indicate 
14c counts. 
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assay conditions using a 15 minute incubation period resulted 
in a much smaller dual-labelled peak (results not shown). 
Adenosine as Substrate 
The ability of adenosine to serve as an acceptor of 
the isopentenyl group was tested in the next series of 
assays. A 60 minute incubation was tried first with unlabelled 
adenosine. Complete assay conditons are listed in Table 1 
under Experiment 5. The anion exchange elution profile 
(Fig. 12) reveals peaks A2 and Bl as possible candidates 
for an enzyme catalyzed product. Peaks Cl and C2 correspond 
to d2 and a3-iPP respectively. Peaks A2 and Bl were absent 
in the control run. Peak Bl was then further analyzed 
on Sephadex LH20 (Fig. 13). Two peaks of 14c counts resulted, 
Ll and L2. Peak L2 co-eluted with a zeatin standard. 
Fractions in peak L2 were combined and found not to be 
volatile during rotoevaporation. Final confirmation of the 
identity of Ll and L2 by HPLC yielded unexpected results. 
Both co-eluted with an adenosine standard, which eluted 
earlier than the zeatin standard (results not shown). 
The next experiment made use of 3H-labelled adenosine, 
and the reaction was also incubated for 60 minutes (Fig. 14). 
Peak A2 was 3H/14c labelled and eluted in the first step of 
the gradient. An aliquot of this peak (1050 cpm 3H, 1110 
cpm l 4c) was chroma tog r aphed on LH 2 0 and resulted in a 
dual-labelled peak which eluted between zeatin riboside and 
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Figure 12. Dowex Elution Profile: Adenosine+ 14C-iPP 
(Experiment 5). The elution profile reveals four peaks of 
radioactivity: A2, Bl, Cl, and C2. 
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Figure 13. LH 20 Elution Profile. An aliquot of 
peak Bl (1700 cpm 14c) along with zeatin, zeatin riboside, 
and I6Ado standards were loaded onto a Sephadex LH 20 
column. Fractions of 4. 0 ml were collected and O. 5 ml 
aliquots were removed for counting. The data points represent 
14c counts. Absorbance was monitored at 254 nm. 
LH-20 Elution Profile 
N 
.., 
J> 
.... 
-z 
:2' 
"' L2 .4 20 c I!!! rn 
-
c 
o:t 
i.n 
N I 150 ~ V1 cu 00 
u e c 
a. ra 
u 
.ca 
... 
Cl 
100 
.2 
.,, 
.ca 
cs: 
50 
4 8 12 16 20 24 
Fraction Number 
59 
Figure 14. Dowex Elution Profile: 3H-Adenosine + 
14c-iPP (Exoer iment 6). The reaction was incubated for 60 
minutes, and loaded onto a Dowex column. The dashed line 
corresponds to 3H cprn and the solid line corresponds to 14c 
cprn. Peak A2 is a dual-labelled peak. Peaks Cl and C2 
represent d2-iPP and d3-iPP respectively. 
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zeatin standards (data not shown). The same reaction 
incubated for 30. minutes also resulted in a dual-labelled 
peak when run on HPLC. Similarly, this peak did not co-elute 
with any of the standards on HPLC (Fig. 15). 
Adenine as Substrate 
Adenine was tried in the reaction mixture as the 
i sopentenyl group acceptor. Initial results showed a 14c 
peak eluting in the first step of the anion exchange column, 
which appeared to be identical to A2 (Fig. 16). However 
due to the low level of radioactive incorporation, further 
identification of this product was not pursued. 
Expression of the Mitochondrial Genome 
In an attempt to discern whether the gene for 
isopentenyltransferase is located on the mitochrondrial 
genome, enzyme isolation was performed from yeast grown in 
medium containing glycerol (YPG). The presence of the 
non-fermentable carbon source, glycerol, evokes expression 
of the mitochondrial genome. Fewer mitochondria are present 
in glucose-repressed cells than in fully respiring cells 
such as when glycerol is present {Stevens, 1981). Wild 
type yeast was used in this experiment and the enzyme 
assays were done with 14c-d3-iPP and 3tt-adenosine or 3tt-5 '-AMP 
at two time points each. In these experiments an aliquot 
of the reaction mixture was directly injected into the 
HPLC. In both cases, the 10 minute incubation resulted in 
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Figure 15. HPLC Elution Profile: 3H-Adenosine + 
14c-iPP (Experiment 7). The reaction was incubated for 30 
minutes, and approximately 5000 cpm 3H and 10,000 cpm 14c 
in 75 ul was injected into the HPLC. The column was eluted 
with a 30-70% aqueous methanol gradient, fractions were 
collected directly into scintillation vials. 
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Figure 16. Dowex Elution Profile: Adenine + 
14c-iPP (Experiment 5). The reaction was incubated for 60 
minutes, and loaded onto a Dowex column. 
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3H and 14c counts clustered at the beginning of the elution 
profile co-eluting with 5'-AMP and 16AMP. The 3 0 minute 
incubation in both cases (14c-d3-iPP and 3H-adenosine or 
3H-5'-AMP) yielded a dual-labelled product with a slightly 
longer retention time than zeatin riboside (Fig. 17). 
Cell Labelling with 14C-Adenine 
Wild type yeast cells were grown in the presence of 
14c-adenine for two incubation periods, 2.0 hours and 6.0 
hours. The labelled cells were harvested, lysed, and the 
intracellular contents were prepared for HPLC analysis as 
described in Materials and Methods. 
At the 2.0 hour time point, two peaks of radioactivity 
are apparent (Fig. 18). Peak A eluted prior to any standard, 
i n d i c a t i n g th a t i t w a s a m or e po 1 a r c om po u n d • Pe a k B 
eluted just prior to the adenine standard in the v ic ini ty 
that adenosine would be expected to elute. No radioactivity 
was found to be associated with any of the later eluting 
cytokinins (zeatin riboside, 16Ado, 16Ade). 
The 6.0 hour time point resulted in only one peak 
of radioactivity which co-eluted with adenine. 
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Figure 17. HPLC Elution Profile: Mitochondrial 
Expression (Experiemnt 8). Standards and sample (5 ul 
reaction mixture) were directly injected into the HPLC. 
The dashed bars represent 3tt cpm and the solid bars represent 
14c cpm. 
A. 3tt-Adenosine + 14c-iPP 
B. 3tt-AMP + 14c-iPP 
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Figure 18. HPLC Elution Profile: 14C-Adenine 
labelling. 100 ul of sample and standards were injected 
into the HPLC. Isocratic elution (55% aqueous methanol) 
revealed two peaks of radioactivity, A and B. 
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CHAPTER V 
DISCUSSION 
To date, the only non-plant associated systems 
shown to possess a de novo pathway for cytokinin production 
are slime mold (Taya et al. 1978) and the crown-gall inducing 
bacterium A. tumefacians (Barry et al., 1984). In addition, 
Chen and Melitz (1979) and Nishinari and Syono (1988b) have 
demonstrated the existence of tRNA-independent pathways in 
tobacco tissue utilizing an in vitro cell-free enzyme 
assay. Direct evidence for the biosynthesis of cytokinins 
in yeast has not previously been reported. This study 
represents the first indication that the yeast, s. cerevisiae 
contains an enzyme system capable of synthesizing products 
derived from 14c-d2-iPP and 3H-5 '-AMP or 3H-adenosine, in 
vitro. Since this enzyme had not been assayed for in 
yeast previously, the primary objective of this study was 
to establish and optimize assay conditions. Therefore it 
was necessary to utilize a crude enzyme preparation in the 
development of the assay to ensure detection of activity. 
The source of the enzyme was the mod 5-1 mutant. The 
advantage in using this mutant was the elimination of 
substrate (d2-iPP) competition between the tRNA-dependent 
transferase and the de novo transferase. 
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Substrate Requirements 
Previous studies that have examined substrate 
requirements for the purified tRNA-independent d2-iPP-iso-
pentenyltransferase enzyme in tobacco tissue (Chen, 1982) 
slime mold (!hara et al., 1984), and A. tumefacians (Barry 
et al., 1984) have tested the purine adenine, the nucleoside 
adenosine, and the mono-, di-, and trinucleotides AMP, ADP, 
and ATP as the acceptor molecules. In view of the structure 
of isopentenyladenosine and its numerous derivatives (Fig. 1), 
this choice of acceptor substrates seems logical. Comparing 
the results of previous studies, it is apparent that the 
substrate requirements differ for each enzyme (Table 2). 
It might be expected that plants, slime mold and bacteria 
would possess distinct forms of the enzyme. This study 
using yeast concludes that 5'-AMP, adenosine, and possibly 
adenine are all capable of accepting the isopentenyl group 
from 14c-d2-iPP to form a single molecule. Adenine has not 
positively been shown to be an acceptor molecule since 
dual-labelled studies were not performed. However, the 
positive iden ti f ica t ion of products, cytok in ins or otherwise, 
proved to be elusive. 
Substrate: 5'-AMP 
3H-5'-AMP and 14c-d2-iPP were shown to yield a 
dual-labelled product. The retention of the dual label in 
three chromatographic systems (Dowex anion exchange, Sephadex 
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TABLE 2.--Summary of Substrate Requirements for Tobacco, 
Slime Mold, and A. tumefacians Enzymes 
A. tume-
Substrate Slime Mold* Tobacco Tissue** facians*** 
Substrate (in vitro) (in vivo) (in vitro) (in vitro) 
Adenine ++ 
Adenosine NA 
5'-AMP ++ NA ++ ++ 
ADP + NA NA NA 
ATP NA NA NA 
I no sine NA NA NA 
cAMP NA NA NA 
Guanine NA NA NA 
GMP NA NA NA 
* Taya et al. (1978). 
**Chen and Melitz (1979); Chen (1982). 
***Barry et a 1 • ( 1 9 8 4 ) • 
NA--Results not available. 
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LH-20, and RP-HPLC) implies that the product was in fact a 
single molecular species. The volatility of this product 
however, leads one to question the identity of this compound 
since cytokinins are not known to be volatile. If this 
product is indeed a cytokinin, it is apparently a novel 
compound. Further structural analysis by mass spectrometry 
or nuclear magnetic resonance is necessary to confirm its 
structure. Information about the stoichiometric relationship 
of the product was obtained by calculating the 3H/14c ratio 
and was found to be in agreement with a 1:1 ratio. 
Substrate: Adenosine 
When adenosine was used in the reaction, both the 
unlabelled and tritiated forms of the molecule were capable 
of reacting to yield products which were not found in the 
boiled control runs. Unlike the reaction utilizing 5'-AMP, 
the product was not volatilized by rotoevaporation. The 
stable nature of the compound and the fact that product 
remained dual-labelled in all of the chromatographic systems 
was encouraging. However similar to the results using 
5'-AMP, the identification of product proved to be difficult 
because it did not co-elute with any of several commercially 
available standards. 
There was a discrepancy between products obtained 
using cold adenosine and 3H-adenosine even though all other 
parameters were comparable. The anion exchange column from 
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the reaction using unlabelled adenosine resulted in two 
peaks of radioactivity, A2 (eluted in O. 0 M KCl) and Bl 
(eluted in 0.1 M KCl) which were both absent in the control. 
When 3H-adenosine was used, the anion exchange results 
showed only one dual-labelled peak, A2, which was not found 
in the control. The absence of Bl in this reaction is 
puzzling. Bl was shown to be comprised of two components, 
Ll and L2 which were resolved on Sephadex LH-20. L2 co-eluted 
with authentic zeatin on LH-20, however upon further analysis 
on HPLC, the compound eluted much earlier than zeatin, 
indicative of a somewhat more polar structure than zeatin. 
This behavior is suggestive of chemical alteration. It is 
possible that the "zeatin-like" product may have decomposed 
yielding an altered structure. 
Peak A2 which was obtained using 3H-adenosine was 
intermediate in hydrophobicity between zeatin and zeatin 
r ibos id e as inf erred from Sephadex LH-2 0 chromatography. 
Separate experiments at three incubation periods (15, 30, 
and 60 minutes) revealed a dual-labelled compound on the 
HPLC, which could not be identified. More rigorous structural 
analysis as mentioned previously is indicated. 
Substrate: Adenine 
It appears that adenine can participate in the 
reaction to yield an enzymatic product. Further experimentation 
using adenine was not pursued due to the initial results 
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which showed minimal rad ioac ti ve incorpo ration in peak A2 
when compared to other substrates used. 
In Vivo 14c-Adenine Labelling 
Although adenine, adenosine, and 5'-AMP seem to be 
logical substrates, it is also possible that these molecules 
may not be specific substrates in vivo. Experiments attempting 
to label cytokinins in vivo by growing yeast in the presence 
of 14c-adenine resulted in no incorporation into cytokinins. 
In referring to the purine biosynthetic pathway (Fig. 3), 
it can be seen that there are limited candidates capable of 
accepting the isopentenyl group. Only adenine, adenosine, 
and AMP possess nitrogen in position 9 on the purine ring, 
inosine and hypoxanthine do not. Chen (1982), tested 
inosine and found it was not a substrate for the enzyme. 
This study represents the only attempt which tested a 
purine pr~cursor. Since yeast cells will not take up many 
compounds (Adenosine, 5'-AMP, Inosine) it would be necessary 
that these studies be performed in vitro. Another explanation 
for the lack of 14c-adenine incorporation into cytokinins 
may be found in recent evidence which links mevalonate 
derived isoprenoids with specific cell proteins (Schmidt et 
al., 1984). I6Ado is cited among others as a possible 
candidate in this assoc ia ti on. If cytoki n ins are indeed 
linked to protein in vivo, 14c-adenine labelling would 
result in incorporation into a protein fraction instead. 
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Incorporation of label into free I6Ado might be transient 
and virtually undetectable. 
In addition, it is possible that endogenous levels 
of cytokinins may fluctuate with the cell cycle. Nishinari 
and Syono (1980a) introduced the first evidence in support 
of this showing a 5 to 10 fold increase of endogenous 
cytokinins which paralleled mitosis in partially synchronized 
tobacco cells. 
Optimization of Assay Parameters 
In developing this assay, the only indication of 
enzymatic activity was in the identification of products 
which were absent in the control. Initial experiments were 
adapted from the procedure of Chen and Melitz (1979). 
Using their buffer system (7.0 mM Tris-HCl, pH 7.0; 20 mM 
MgCl2; 35 mM MnCl2; 3.5 mM 2-mercaptoethanol; 7.0 mM KF) at 
37 C, virtually no product formation was observed. Subse-
quently the assay system of Taya et al. (1978) was tested 
(20 mM Tris-HCl, pH 7.6; 5.0 mM magnesium acetate) incubated 
at 25 C, and adopted for use in all succeeding experiments. 
Different incubation periods were used in the hope of 
characterizing the biosynthetic pathway. However due to 
the difficulty in product identification, this information 
was not obtainable from the results. In terms of the 
amount of product formed, thirty minutes to one hour incuba-
tion was optimum. 
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In order to determine whether the gene for d2-iPP-
i sopentenyl trans£erase might be located on the mitochondrial 
genome, and therefore would require mitochondrial expression, 
the yeast cells were grown in YPG medium which contains 
glycerol as the carbon source. Results of the assays when 
the enzyme was prepared from cells grown in YPG medium did 
not appear to be different than those when enzyme was 
prepared from cells grown in YPD medium. This suggests the 
enzyme ( s) responsible for the synthesis of the products 
observed were probably not mitochondrial. 
Summary 
The mod 5-1 mutant of Saccharomyces cerevisiae has 
been shown to possess an enzyme system responsible for the 
apparent isopentenylation of 5'-AMP, adenosine, and adenine 
using a2-iPP as the donor molecule. The failure of these 
products to co-elute with any authentic cytokin in implies 
that these products may be novel compounds not yet identified 
as cytokinins. Several investigators have described metabolic 
enzymes which interconvert these molecules to different 
forms. These enzymes include 5'-nucleotidases which dephos-
phorylate cytokinin nucleotides (Chen & Kristopeit, 198la), 
adenosine nucleosidases which are responsible for the 
deribosylation of cytokinin nucleosides (Chen & Kristopeit, 
198lb), adenine phosphoribosyltransferases which converts 
cytokinin bases to their corresponding nucleotides (Chen et 
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al., 1982), and mixed function ox idases which hydroxylate 
I 6Ade and I 6Ad o to zea tin and zea tin r iboside respectively 
(Chen, 1982). It is possible that yeast may contain other 
metabolic enzymes, thus generating alternate structures. 
Obviously more structural analysis is needed to 
identify these products, in addition to a cytokinin bioassay 
to determine whether these molecules have cytokinin activity 
in plants. The importance of the biosynthesis of these 
molecules in yeast may be significant in light of their 
proposed involvement in DNA replication (Quesney-Huneeus et 
al., 1980), their role as anti-tumor agents (Trewyn & Kerr, 
1979; Tritsch, 1973) and their immunosuppressive effects 
(Hacker & Feldbush, 1969). Yeast represent an excellent 
organism in which to study the mechanism of these effects. 
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